TP53 and head and neck squamous cell carcinoma: Within those of European ancestry, rs78378222 a 3’ UTR variant in TP53, was associated with a reduced risk of HNSCC overall, (OR (95% CI) = 0.62 (0.52, 0.73), p = 2.16 × 10−8) (Fig. 2a).